BWAY.TA TLV
BrainsWay Ltd.
1W: -10.6%
1M: -6.1%
3M: +21.7%
YTD: +21.7%
1Y: +150.3%
3Y: +1246.0%
5Y: +200.8%
₪4,431.00 ($15.15)
+39.00 (+0.89%)
Weekly Expected Move ±6.1%
₪4051
₪4331
₪4610
₪4889
₪5169
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₪1.8B ($6.0M)
52W Range1810-5123
Volume160,720
Avg Volume113,957
Beta1.44
Dividend—
Analyst Ratings
Company Info
CEOHadar Levy
Employees120
SectorHealthcare
IndustryMedical - Devices
IPO Date2007-03-28
Websitebrainsway.com
Bynet Building
Jerusalem 9777518
IL
Jerusalem 9777518
IL
972 2 582 4030
About BrainsWay Ltd.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Latest News
No recent news
Recent Insider Trades
No insider trades found